Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2489-2493

  Lamerz, Rolf ^a   Runge, Matthias ^a   Stieber, Petra ^a   Meissner, Elke ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Des gamma carboxy prothrombin (DCP) PIVKA II; Hepatocellular carcinoma; Tumor marker

Indexed keywords

ALPHA FETOPROTEIN; DICOUMAROL; PROTHROMBIN; TUMOR MARKER; WARFARIN;

ADULT; ALCOHOL LIVER CIRRHOSIS; BLOOD LEVEL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; VITAMIN K DEFICIENCY;

ADULT; AGED; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROTEIN PRECURSORS; PROTHROMBIN; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032781041     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, Coleman MS, Furie B: Des-g-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310: 1427-1431, 1984.
2. Weitz IC, Liebman HA: Des-y-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology 18: 990-997, 1993.
3. Naraki T, Watanabe K, Shimozuru Y et al: Development and evaluation of EIA kit for the detection of PIVKA-II using double antibody sandwich system; monoclonal antibody to PIVKA-II and polyclonal antibody to prothrombin. Clin Immunol (Japanese) 18: 479-492, 1986.
4. Kihara K et al: J Japan Pediatric Soc 88: 1508, 1984.
5. Amiral J, Grosley M, Plassart V, Mimilla F, Chambrette B: Development of a monoclonal immunoassay for the direct measurement of decarboxyprothrombin on plasma. Thromb Haemost 65: 10, 1991.
6. Lamerz R, Rjosk H, Schmalhorst U, Fateh-Moghadam A: Alpha-Fetoprotein. Methodik und klinische Erfahrungen mit einem neuen Radioimmunoassay. Z Anal Chem 279: 120, 1976.
7. Yamagata H, Nakanishi T, Furukawa M, Okuda H, Obata H: Levels of vitamin K, immunoreactive prothrombin, des-γ-carboxy prothrombin and γ-glutamyl carboxylase activity in hepatocellular carcinoma tissue. J Gastroenterol and Hepatol 10: 8-13, 1995.
8. Fujiyama S, Izuno K, Yamasaki K, Sato T, Taketa K: Determination of optimum cutoff levels of plasma des-γ-carboxy prothrombin and serum α-fetoprotein for the diagnosis of hepatocellular carcinoma using receiver operating characteristic curves. Tumor Biol 13: 316-323, 1992.
9. Kasahara A, Hayashi N, Fusamoto H, Kawada Y, Imai Y, Yamamoto H, Hayashi E, Ogihara T, Kamada T: Clinical evaluation of plasma des-γ-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes. Digest Dis Sci 38: 2170-2176, 1993.
10. Nakao A, Taniguchi K, Inoue S, Harada A, Nonami T, Watanabe K, Takagi H: Usefulness of simultaneous determination of α-fetoprotein and des-γ-carboxy-prothrombin in hepatocellular carcinoma. Seminars in Surg Oncol 12: 160-163, 1996.
11. Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T: Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Cancer 73: 2464-2471, 1994.
12. Saitoh S, Ikeda K, Koida I, Tsubota A, Arase Y, Chayama K, Kumada H: Serum des-γ-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas. Cancer 74: 2918-2923, 1994.
13. Nakao A, Virji A, Iwaki Y, Carr B, Iwatsuki S, Starzl E: Abnormal prothrombin (des-γ-carboxy prothrombin) in hepatocellular carcinoma. Hepatogastroenterol 38: 450-453, 1991.
14. Suehiro T, Matsumata T, Itasaka H, Taketomi A, Yamamoto K, Sugimachi K: Des-γ-carboxy prothrombin and proliferative activity of hepatocellular carcinoma. Surgery 117: 682-691, 1995.
15. Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Sugimachi K: Des-γ-carboxy prothrombin and α-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma. Cancer 78: 2094-2100, 1996.